These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 1976516

  • 1. Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion.
    Brüne B, Schmidt KU, Ullrich V.
    Eur J Biochem; 1990 Sep 24; 192(3):683-8. PubMed ID: 1976516
    [Abstract] [Full Text] [Related]

  • 2. Effect of carnosine on the activation of human platelet soluble guanylate cyclase by sodium nitroprusside and protoporphyrin IX.
    Severina IS, Busygina OG.
    Biochem Int; 1990 Nov 24; 22(3):455-65. PubMed ID: 1981669
    [Abstract] [Full Text] [Related]

  • 3. Soluble guanylate cyclase of platelets: function and regulation in normal and pathological states.
    Severina IS.
    Adv Enzyme Regul; 1992 Nov 24; 32():35-56. PubMed ID: 1353937
    [Abstract] [Full Text] [Related]

  • 4. [Guanylate cyclase from human blood platelets].
    Chirkov IuIu, Tyshchuk IA, Belushkina NN, Severina IS.
    Biokhimiia; 1987 Jun 24; 52(6):956-63. PubMed ID: 2889477
    [Abstract] [Full Text] [Related]

  • 5. [An endogenous regulator of the guanylate cyclase activity of human platelets].
    Busygina OG, Severina IS.
    Biokhimiia; 1990 Oct 24; 55(10):1812-8. PubMed ID: 1981850
    [Abstract] [Full Text] [Related]

  • 6. Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation.
    Craven PA, DeRubertis FR.
    J Biol Chem; 1978 Dec 10; 253(23):8433-43. PubMed ID: 30778
    [Abstract] [Full Text] [Related]

  • 7. [Heme deficiency of soluble guanylate cyclase in rat platelets].
    Busygina OG, Severina IS.
    Biokhimiia; 1991 Mar 10; 56(3):487-93. PubMed ID: 1679351
    [Abstract] [Full Text] [Related]

  • 8. Role of heme in the regulation of human and rat platelet soluble guanylate cyclases.
    Severina IS, Busygina OG.
    Biochem Int; 1991 Apr 10; 23(6):1143-54. PubMed ID: 1683234
    [Abstract] [Full Text] [Related]

  • 9. [Soluble forms of guanylate cyclases: mechanism of activation by nitrogen oxide and role in platelet aggregation].
    Severina IS.
    Vestn Ross Akad Med Nauk; 1995 Apr 10; (2):41-6. PubMed ID: 7756930
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase.
    Brüne B, Ullrich V.
    Mol Pharmacol; 1987 Oct 10; 32(4):497-504. PubMed ID: 2890093
    [Abstract] [Full Text] [Related]

  • 11. [The role of heme in activating rat myocardial guanylate cyclase by sodium nitroprusside].
    Miroshnichenko VP, Severina IS.
    Biokhimiia; 1995 Apr 10; 60(4):499-507. PubMed ID: 7779974
    [Abstract] [Full Text] [Related]

  • 12. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R.
    Cardiovasc Res; 2006 Jul 15; 71(2):393-401. PubMed ID: 16713591
    [Abstract] [Full Text] [Related]

  • 13. Effect of nitroso complexes of some transition metals on the activity of soluble guanylate cyclase.
    Severina IS, Bussygina OG, Grigorjev NB.
    Biochem Int; 1992 Mar 15; 26(4):695-705. PubMed ID: 1351725
    [Abstract] [Full Text] [Related]

  • 14. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A, Bauersachs J, Schäfer A, Stasch JP, Kast R, Busse R.
    Br J Pharmacol; 1997 Feb 15; 120(4):681-9. PubMed ID: 9051308
    [Abstract] [Full Text] [Related]

  • 15. [Conditions of activation of guanylate cyclase from human platelets].
    Chirkov IuIu, Tyshchuk IA, Severina IS.
    Biokhimiia; 1988 Sep 15; 53(9):1520-6. PubMed ID: 2904828
    [Abstract] [Full Text] [Related]

  • 16. [The role of carnosine in the function of soluble of guanylate cyclase].
    Severina IS, Busygina OG.
    Biokhimiia; 1992 Sep 15; 57(9):1330-6. PubMed ID: 1361362
    [Abstract] [Full Text] [Related]

  • 17. Factors affecting the activity of guanylate cyclase in lysates of human blood platelets.
    Adams AF, Haslam RJ.
    Biochem J; 1978 Jul 15; 174(1):23-35. PubMed ID: 29607
    [Abstract] [Full Text] [Related]

  • 18. Requirement for heme in the activation of purified guanylate cyclase by nitric oxide.
    Craven PA, DeRubertis FR.
    Biochim Biophys Acta; 1983 Jun 29; 745(3):310-21. PubMed ID: 6134553
    [Abstract] [Full Text] [Related]

  • 19. Reversible activation of soluble guanylate cyclase by oxidizing agents.
    Wu XB, Brüne B, von Appen F, Ullrich V.
    Arch Biochem Biophys; 1992 Apr 29; 294(1):75-82. PubMed ID: 1347985
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    Mellion BT, Ignarro LJ, Myers CB, Ohlstein EH, Ballot BA, Hyman AL, Kadowitz PJ.
    Mol Pharmacol; 1983 May 29; 23(3):653-64. PubMed ID: 6135148
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.